Leading academic and pharmaceutical researchers and clinicians from many
disciplines synthesize and summarize current clinical and basic
knowledge concerning abnormal growth of blood vessels in the eye, the
cause of major neovascular eye diseases. The authors also identify and
assess the most promising approaches with potential for commercial
exploitation and discuss the challenges encountered in developing
therapeutics for ocular neovascular diseases. Highlights include
illuminating chapters on gene therapy and novel drug delivery systems
and excellent summaries of the newest therapeutic approaches.